Nanomedicine-Based Approaches for mRNA Delivery

Area of Science:

• Biotechnology
• Nanomedicine
• Therapeutic Development

Background:

• Messenger RNA (mRNA) holds significant therapeutic potential for immunotherapy and protein replacement due to its non-integrating nature and ability to function in non-dividing cells.
• However, mRNA's large size, immunogenicity, poor cellular uptake, and susceptibility to degradation limit its clinical application.
• Existing strategies like structural modifications improve mRNA stability and reduce immunogenicity, but effective delivery remains a challenge.

Purpose of the Study:

• To review recent advancements in nanomedicine-based strategies for enhancing mRNA delivery and function.
• To highlight the application of engineered nanomedicines in protecting, delivering, and releasing mRNA for therapeutic purposes.
• To discuss the potential for clinical translation of these nanomedicine-mRNA approaches.

Main Methods:

• Review of current literature on nanomedicine applications for mRNA delivery.
• Analysis of strategies for engineering nanocarriers to protect mRNA from degradation.
• Evaluation of methods for controlling mRNA release and enhancing cellular uptake via nanomedicine formulations.

Main Results:

• Nanomedicine offers precise control over the spatiotemporal function of mRNA in vivo.
• Engineered nanostructures can protect mRNA, facilitate its delivery, and promote translation.
• Significant progress has been made in overcoming mRNA's inherent limitations through nanocarrier development.

Conclusions:

• Nanomedicine is crucial for advancing mRNA-based therapeutics by addressing delivery and stability challenges.
• Engineered nanomedicines are key to unlocking the full therapeutic potential of mRNA for various diseases.
• Further research and development in this area are essential for successful clinical translation.